🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Superficial Bladder Cancer

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer NCT03379909Phase 23 sites📍 Nijmegen📍 Rotterdam📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Metformin Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer NCT06889623NA1 site📍 Shanghai Changhai Hospital · Tests: Immediate postoperative chemotherapy A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites📍 Bakersfield📍 New Brunswick📍 Myrtle Beach Merck Sharp & Dohme LLC · Tests: MK-3120 A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing NCT07036731NA1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Urine biomarker -Guided without reTURBT Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer NCT06441110Phase 31 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Tislelizumab in Combination with Bacillus Calmette-Guérin Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy NCT07144319n/a12 sites📍 Tampa📍 Iowa City📍 Ann Arbor Photocure A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC NCT05410730Phase 1, Phase 21 site📍 Beijing Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-1501 Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer NCT07187635NA7 sites📍 Nanchang📍 Guangzhou📍 Xingtai Tianjin Medical University Second Hospital · Tests: Second Transurethral Resection of Bladder Tumor (re-TURBT), utDNA Testing (Urine Tumor DNA Detection) Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer NCT06732531Phase 1, Phase 26 sites📍 Beijing📍 Xiamen📍 Changsha Zhuhai Beihai Biotech Co., Ltd · Tests: BH011 A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer NCT07804056Phase 31 site📍 Prague Hamlet Pharma AB · Tests: Alpha1H, Transurethral Resection of Bladder Tumor (TURBT), Intravesical Chemotherapy Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy NCT07000084Phase 360 sites📍 Birmingham📍 Fairbanks📍 Gilbert Alliance for Clinical Trials in Oncology · Tests: BCG Solution, Biopsy of Bladder, Cystoscopy, Computed Tomography, Magnetic Resonance Imaging Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration NCT07307456Phase 21 site📍 Shanghai Changhai Hospital · Tests: Treatment with toripalimab combined with BCG perfusion following transurethral resection of bladder tumor (TURBT) LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve NCT04752722Phase 1, Phase 2102 sites📍 Birmingham📍 Scottsdale📍 Tucson enGene, Inc. · Tests: EG-70 (phase 1), EG-70 (phase 2) Master Protocol, Surfactant Bladder Pre-Rinse and EG-70 (Substudy) Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer NCT07673016n/a23 sites📍 Oceanside📍 San Diego📍 San Jose Convergent Genomics, Inc. Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer NCT07474519Phase 41 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Accelerometry, BCG Solution, BCG Solution, BCG Solution, Electronic Health Record Review Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer NCT07420517Phase 21 site📍 Québec Paul Toren · Tests: Dutasteride (0.5mg) A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy NCT06351904Phase 13 sites📍 St Leonards📍 Melbourne📍 Melbourne Ractigen Therapeutics. · Tests: RAG-01 The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy NCT06388720Phase 21 site📍 Goyang-si National Cancer Center, Korea · Tests: Mitomycin-C, gemcitabine Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial NCT07302230NA1 site📍 Seattle University of Washington · Tests: Internet-Based Intervention, Best Practice, Internet-Based Intervention, Exercise Intervention, Health Telemonitoring A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer NCT06245603NA9 sites📍 Bergamo📍 Bologna📍 Foggia Istituto Oncologico Veneto IRCCS · Tests: Hydeal Cyst® A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in Portugal NCT07784387n/a1 site📍 Lisbon Janssen-Cilag Farmaceutica Ltda. Feasibility of Automatic, Laser-based Distance Control in Persons With Superficial Bladder Tumors NCT07860398NA1 site📍 Herlev Optheras AS · Tests: ATLAS system A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer NCT06735287NA1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: bladder sparing set, RC Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer NCT05337397n/a1 site📍 Aarhus Jørgen Bjerggaard Jensen · Tests: Laser ablation A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) NCT06108492Phase 11 site📍 Shanghai Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-2005 DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr NCT04106115Phase 1, Phase 27 sites📍 Cambridge📍 London📍 London University College, London · Tests: Durvalumab, S-488210/S-488211 A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer NCT07122414Phase 1, Phase 212 sites📍 Beijing📍 Beijing📍 Fuzhou Suzhou Forlong Biotechnology Co., Ltd · Tests: FL115, FL115+BCG Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients NCT06696794Phase 33 sites📍 Wuhan📍 Wuhan📍 Xiangyang Shaogang Wang · Tests: Mitomycin C (MMC), Normal Saline (Placebo) A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy NCT07468851Phase 1, Phase 22 sites📍 Beijing📍 Nanjing Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-10566, HS-10566, HS-10566 A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC NCT07726992Phase 32 sites📍 Beijing📍 Guangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-1501+BCG, Placebo +BCG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy